Related references
Note: Only part of the references are listed.The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes
Peter C. Austin et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2017)
Proton Pump Inhibitors and the Prescribing Cascade
Mohammad Rababa et al.
JOURNAL OF GERONTOLOGICAL NURSING (2016)
Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer
Roelof W. F. van Leeuwen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non-Small-Cell Lung Cancer
Michael P. Chu et al.
CLINICAL LUNG CANCER (2015)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Does gastric acid suppression affect sunitinib efficacy in patients with advanced or metastatic renal cell cancer?
Vincent H. Ha et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2015)
Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective
Roelof W. F. van Leeuwen et al.
LANCET ONCOLOGY (2014)
Determining the optimal dose in the development of anticancer agents
Ron H. J. Mathijssen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Prevalence of Acid-Reducing Agents (ARA) in Cancer Populations and ARA Drug-Drug Interaction Potential for Molecular Targeted Agents in Clinical Development
Gillian S. Smelick et al.
MOLECULAR PHARMACEUTICS (2013)
An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib
J. F. Hilton et al.
LUNG CANCER (2013)
Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH-Dependent Solubility the Achilles Heel of Targeted Therapy?
N. R. Budha et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Safe practices and financial considerations in using oral chemotherapeutic agents
Sylvia B. Bartel
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Oral chemotherapy safety practices at US cancer centres: questionnaire survey
Saul N. Weingart et al.
BRITISH MEDICAL JOURNAL (2007)
Role of tyrosine kinase inhibitors in cancer therapy
A Arora et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Tyrosine kinases as targets for cancer therapy
DS Krause et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
